Génome Canada

Génome Canada
Génome Québec

Génome Québec

October 26, 2005 07:00 ET

Media Advisory/The haplotype map of the Human Genome 'HapMap' is Now Completed

OTTAWA, CANADA--(CCNMatthews - Oct. 26, 2005) - A major announcement in health and scientific research will be released on the Internet on Wednesday, October 26, at 1:45 pm ET, at www.genome.gov

Embargoed until 1:00 pm, Wednesday, October 26 (i)

The fight against current diseases reaches a crucial stage

The haplotype map of the human genome (HapMap) is now completed

Two prominent Canadian researchers play a key role in the project

Next Wednesday, the International HapMAP Consortium will launch the haplotype map (a catalog of representative genetic similarities and differences in human beings), resulting from one of the most significant worldwide research projects since the sequencing of the human genome. The consortium, a collaboration of 6 countries (Canada, China, Japan, Nigeria, the United Kingdom and the United States), will release this statement at a press conference in the opening of the 2005 Congress of American Society of Human Genetics in Salt Lake City (Utah), October 25-29.

This international initiative, funded up to 10% by Genome Canada and Genome Quebec, made it possible for two prominent Quebec researchers to play a key role as leaders in the field of genomics research and ethics. Dr. Thomas Hudson, Director of the McGill University and Genome Quebec innovation Centre, who co-chaired this project, and Mrs. Bartha Knoppers, professor at the Faculte de droit de l'Universite de Montreal, senior researcher at the Centre de recherche en droit public (Research center in public law, or CRDP) and chair of the Canada Research in Law and Medicine, will be attending the press conference and answer any questions put to them online, in real time, on the Internet.

Using the information in the HapMap project, researchers from all over the world will be able to find genes responsible for current diseases such as autoimmune diseases, schizophrenia, diabetes, asthma, cerebrovascular accidents and heart attacks, and also individual responses to medications and environmental factors.

If you are interested in attending this conference:

- Toll-free number dedicated to the press conference: 800-967-7188
- Local number: 719-457-2636 (long distance charges may apply)
- Confirmation code: 4623975


To help ensure the lecturers' schedule, we suggest that you dial in 5 to 10 minutes prior to the scheduled start time of 1:45 pm. To reduce background noise, please dial in from a phone that has a mute button and keep it pressed unless you are speaking. If the toll-free number is unavailable, please dial the local United States Premiere Conference Services non-toll free number at (719) 457-2636. Provide the number where you can be reached along with the confirmation code indicated above and the operator will call you back shortly.

Documentation and interviews

Reporters will be able to obtain a "questions and answers" document, as well as photographs of Dr. Hudson and Mrs. Knoppers, and specific interviews upon request to Mrs. Evelyn Dubois, (office # 514.527.3983, cell phone # 514.770.3983) or to Mrs. Anie Perrault, Genome Canada, which will be on site (or can be reached at 514.258.7629).

For more information about Genome Quebec: www.genomequebec.com
For more information about Genome Canada: www.genomecanada.ca


The date and time embargo on information to be released adheres to the agreement signed by the publisher of the magazine Nature Genomics which publishes in extinso the results of the HapMap project.

Contact Information

  • Mrs. Evelyn Dubois
    (514) 527-3983 (office)
    (514) 770-3983 (cell)
    Genome Canada
    Mrs. Anie Perrault
    (514) 258-7629